Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfentanil versus sufentanil combined with ropivacaine for epidural labor analgesia
ChiCTR2300072104Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of alfentanil, sufentanil and ropivacaine in labor pain (2 arms), sponsored by General Hospital of the Northern Theater Command. Primary endpoint: Median time to VAS score <= 3 within 30 minutes after epidural analgesia. Planned start Jun 2023; status: not yet recruiting.
02
Drugs
alfentanilsufentanilropivacaine
03
Conditions
labor pain
Beyond the preview
Go deeper on ChiCTR2300072104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072104.